Arbutus Biopharma Corp. buy melinda
Start price
16.10.18
/
50%
€4.19
Target price
02.11.18
€6.31
Performance (%)
13.55%
End price
02.11.18
€4.76
Summary
This prediction ended on 02.11.18 with a price of €4.76. The prediction had a final performance of 13.55%. melinda has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Arbutus Biopharma Corp. | -0.844% | -0.844% | 80.266% | 50.619% |
iShares Core DAX® | -0.116% | 1.953% | 14.155% | 16.268% |
iShares Nasdaq 100 | -2.733% | -1.273% | 31.828% | 43.377% |
iShares Nikkei 225® | -1.721% | 3.263% | 12.922% | 8.501% |
iShares S&P 500 | -1.527% | 0.194% | 27.117% | 41.752% |
According to melinda what are the pros and cons of Arbutus Biopharma Corp. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by melinda for this prediction
In the thread Arbutus Biopharma Corp. diskutieren
SecteurProduits pharmaceutiques Agenda 08/11 Publication de résultats
Arbutus Biopharma Corp. is a biopharmaceutical company, engages in discovering, developing and commercializing a cure for patients suffering from chronic Hepatitis B virus infection.
The company was founded on October 6, 2005 and is headquartered in Burnaby, Canada.
Nombre d'employés : 130 personnes.
(Vom Mitglied beendet)
Stopped prediction by melinda for Arbutus Biopharma Corp.
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.20
24.12.23
24.12.23
-
24.12.24
24.12.24
1.36%
06.01.24
06.01.24
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.03
08.07.23
08.07.23
-
08.07.24
08.07.24
-18.91%
26.11.23
26.11.23
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€2.08
20.05.20
20.05.20
€4.50
04.11.21
04.11.21
56.99%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€3.14
06.01.20
06.01.20
-
20.05.20
20.05.20
-33.64%
20.05.20
20.05.20
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€1.73
03.06.19
03.06.19
€2.35
20.06.19
20.06.19
36.98%
20.06.19
20.06.19
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€6.55
21.10.17
21.10.17
€7.50
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year
Arbutus Biopharma Corp.
Start price
Target price
Perf. (%)
€5.91
21.10.17
21.10.17
€6.77
27.12.17
27.12.17
-26.72%
27.12.17
27.12.17
Could be worthwhile Investment >10% per year